Semi-Annual Statement Of Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7729427

Concept 2017-04-01 to
2017-12-31
2016-04-01 to
2016-12-31
Semi-annual statement of income
Statement of income
Net sales
35,454,000,000 JPY
36,202,000,000 JPY
Cost of sales
25,228,000,000 JPY
26,016,000,000 JPY
Ordinary profit (loss)
809,000,000 JPY
780,000,000 JPY
Gross profit (loss)
10,226,000,000 JPY
10,186,000,000 JPY
Extraordinary income
567,000,000 JPY
477,000,000 JPY
Selling, general and administrative expenses
9,440,000,000 JPY
9,438,000,000 JPY
Extraordinary losses
29,000,000 JPY
17,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
785,000,000 JPY
747,000,000 JPY
Profit (loss) before income taxes
1,347,000,000 JPY
1,240,000,000 JPY
Income taxes - current
235,000,000 JPY
363,000,000 JPY
Non-operating income
307,000,000 JPY
333,000,000 JPY
Non-operating income
Interest income
15,000,000 JPY
15,000,000 JPY
Dividend income
64,000,000 JPY
64,000,000 JPY
Income taxes - deferred
168,000,000 JPY
-84,000,000 JPY
Income taxes
403,000,000 JPY
278,000,000 JPY
Non-operating expenses
283,000,000 JPY
300,000,000 JPY
Non-operating expenses
Interest expenses
165,000,000 JPY
168,000,000 JPY
Profit (loss)
943,000,000 JPY
961,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
567,000,000 JPY
477,000,000 JPY
Extraordinary losses
Loss on sale of non-current assets
JPY
5,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.